Nicola A Hanania

Languages spoken, written or signed: English

Occupation: physician, university teacher, scientist

Bibliographic databases:

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 153

Date

Title

Authors

2002-05-01

Beta-agonist intrinsic efficacy: measurement and clinical significance

Nicola A Hanania, Burton F Dickey
2002-10-01

Pulmonary-renal syndromes in the intensive care unit

Nicola A Hanania
2003-09-01

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

Nicola A Hanania
2004-04-01

Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy

Robert A. Wise, Nicola A Hanania, Robert L Atmar
2004-09-01

Anti-inflammatory activities of beta2-agonists

Nicola A Hanania
2004-10-01

Acute asthma in pregnancy.

Nicola A Hanania
2005-05-01

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study

Nicola A Hanania
2005-03-01

Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease

Nicola A Hanania
2005-10-18

Treatments for COPD.

Nicola A Hanania
2006-09-15

Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization

Burton F Dickey, Nicola A Hanania
2006-05-01

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults

Nicola A Hanania, Charles L. Emerman
2006-02-01

Influenza vaccine in patients with asthma

Nicola A Hanania, Robert L Atmar
2006-05-12

Revisiting asthma control: how should it best be defined?

Nicola A Hanania
2006-01-01

The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.

Nicola A Hanania
2006-10-23

Predicting episodes of poor asthma control in treated patients with asthma

Nicola A Hanania
2007-02-01

Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial

Nicola A Hanania
2007-07-17

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

Sergio Parra, Burton F Dickey, Clive Page, Nicola A Hanania
2007-03-23

One hundred years of chronic obstructive pulmonary disease (COPD).

Nicola A Hanania
2007-09-01

Update on the pharmacologic therapy for chronic obstructive pulmonary disease

Nicola A Hanania
2007-10-01

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators

Nicola A Hanania
2007-10-01

Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes

Nicola A Hanania
2007-12-01

The potential role of natural agents in treatment of airway inflammation

Nicola A Hanania, Vladimir Badmaev
2008-01-01

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study

David J Pasta, Nicola A Hanania
2008-12-01

Evaluation of obstructive lung disease with vibration response imaging

Nicola A Hanania
2008-02-01

Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials

Nicola A Hanania
2008-10-01

Anxiety and depression in COPD: current understanding, unanswered questions, and research needs

Nicola A Hanania
2008-01-06

The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.

Nicola A Hanania
2008-04-01

Targeting airway inflammation in asthma: current and future therapies

Nicola A Hanania
2008-05-01

Pathogenesis of emphysema: from the bench to the bedside

Nicola A Hanania
2008-06-01

It's about time--directing our attention toward modifying the course of COPD.

Nicola A Hanania
2009-11-01

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

Nicola A Hanania
2009-06-01

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

Nicola A Hanania

Comments

There is nothing here

Lists

There is nothing here

Human -

Welcome to inventaire

The library of your friends and communities

Learn more

Author

Nicola A Hanania

Series

Works

Articles 153

Comments

Lists

Fediverse followers 0

Welcome to inventaire